229 related articles for article (PubMed ID: 16582875)
21. Challenges associated with metabolic syndrome.
Spinler SA
Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy.
López-Candales A
J Med; 2001; 32(5-6):283-300. PubMed ID: 11958275
[TBL] [Abstract][Full Text] [Related]
23. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
24. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
25. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
26. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
27. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
28. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Davidson M
Am J Cardiol; 2008 Dec; 102(12A):19L-27L. PubMed ID: 19084086
[TBL] [Abstract][Full Text] [Related]
29. Sleep and the metabolic syndrome.
Wolk R; Somers VK
Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome and cardiovascular disease.
Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
[TBL] [Abstract][Full Text] [Related]
31. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
Krentz AJ; Clough G; Byrne CD
J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
[TBL] [Abstract][Full Text] [Related]
32. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
33. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
34. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome.
Sasanabe R; Banno K; Otake K; Hasegawa R; Usui K; Morita M; Shiomi T
Hypertens Res; 2006 May; 29(5):315-22. PubMed ID: 16832151
[TBL] [Abstract][Full Text] [Related]
37. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
38. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Jones PH
Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and juvenile idiopathic arthritis.
Zanette Cde A; Machado SH; Brenol JC; Xavier RM
Rev Bras Reumatol; 2010; 50(2):190-204. PubMed ID: 21125154
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome: multiple candidate genes, multiple environmental factors--multiple syndromes?
Nestel P
Int J Clin Pract Suppl; 2003 Mar; (134):3-9. PubMed ID: 12793592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
